Add to Favorites Newsroom RSS Share
fb-shareSbarro Health Research Organization (SHRO)
Philadelphia, PA USA

Our News on Newswise

Brain Cancer Drug Reactivates Body's Natural Defenses

Drug reactivates p53 tumor suppressor protein and increases chemotherapy effectiveness in potential glioblastoma breakthrough.
20-May-2019 4:05 AM EDT Add to Favorites


Enzyme Inhibition May Lead to New Melanoma Therapy, Say Researchers at Fox Chase with Support from Sbarro Institute

Inhibition of the cellular enzyme thymine DNA glycosylase (TDG) may be an effective treatment for melanoma, according to research published in the journal Oncogene in January. The paper, “Thymine DNA glycosylase as a novel target for melanoma,”...
10-Apr-2019 12:05 PM EDT Add to Favorites

Giordano Alfano and Pentimalli.jpg

Decoy Damaged DNA Discovers New Gene Repair Protein

A synthetic DNA structure was used as bait to capture nuclear proteins, revealing previously unknown role of HNRNPD in the cellular response to DNA damage.
14-Mar-2019 9:00 AM EDT Add to Favorites

Potential to Better Treat Mesothelioma Revealed by Precision Medicine Research

Researchers have successfully identified two genetic markers for potentially effective treatment of Mesothelioma, an orphan disease most commonly associated with asbestos exposure, and for which few treatments exist.
4-Feb-2019 11:45 AM EST Add to Favorites

Metastatic Breast Cancer Survival Improves with New CDK-Inhibitor Plus Endocrine Therapy

A study finds that palbociclib, in combination with endocrine therapy, improves progression free survival
11-Dec-2018 7:55 AM EST Add to Favorites


SHRO Partners with Film Festival to Recognize Importance of Virtual Reality in Medicine and Celebrate Italian-Origin Filmmakers

This week, SHRO partners with the Italian Movie Award International Film Festival to support Italian-American work in cinema, particularly in recognition for accomplishments with the use of Virtual Reality (VR) in applications in medicine
10-Dec-2018 2:05 PM EST Add to Favorites


Italian-American Foundation Honors Antonio Giordano, MD, PhD Founder & President of Sbarro Health Research Organization

Italian-American Foundation, Filitalia, honors Antonio Giordano, MD, PhD, Founder & President of Sbarro Health Research Organization at Temple University with the Humanitarian award at the foundation’s 31st Anniversary Gala.
12-Nov-2018 9:00 AM EST Add to Favorites


Dompé at the medical conference “The Impact of Environment and Healthy Lifestyles in Human Health” - October 13th, Washington, D.C

Sbarro Health Research Organization, on the occasion of the medical conference “The impact of environment and healthy lifestyles in human health,” honoured Nathalie Dompé, CEO Dompé Holdings, with a special Award for Societal Impact in...
13-Oct-2018 2:00 PM EDT Add to Favorites

see all news

Our Experts on Newswise


Understanding Cancer Heterogeneity Could Further Reduce Chemo Use, Says Expert

6-Jun-2018 11:35 AM EDT

Cancer DNA Sequencing Has Potential, but Not a Magic Bullet, Says Expert

16-Jan-2018 11:05 AM EST


Thorough Genotyping and Repurposed Drugs Key to Treating Small-Cell Lung Cancer, says Cancer Expert

Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT


Every Diagnosis of Cancer Should Come with One of These, Says Cancer Expert

“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST

see all experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.


Sbarro Health Research Organization conducts research in cancer, diabetes, and cardiovascular disease. Based in Philadelphia, Pennsylvania on the campus of Temple University, our programs train young scientists from around the globe.


  • Antonio Giordano


    Cancer, Diabetes, Heart Disease, Genetics, biomolecular chemistry, Oncology


Barbara Colombo

Antonio Giordano


Twitter twitter-icon

Chat now!